Restenosis after balloon angioplasty and/or stent insertion - Origin and prevention: A review of the literature

Acta Radiologica

Volumn 43, Issue 5, 2002, Pages 442-454

  Ćwikiel, Wojciech ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

Angioplasty; Arteries, stents; Balloon dilation; Interventional procedures; Intimal hyperplasia

Indexed keywords

HUMAN; HYPERPLASIA; INTIMA; PATHOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RECURRENT DISEASE; REVIEW; STENT;

ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; HUMANS; HYPERPLASIA; RECURRENCE; STENTS; TUNICA INTIMA;

EID: 0036716530     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0455.2002.430502.x     Document Type: Review

References (224)

1. AGGRAWAL R. K., IRELAND D. C., AZRIN M. A. et al.: Antithrombic potential of polymer-coated stents eluting platelet glycoprotein IIb/IIIa receptor antibody. Circulation 94 (1996), 3311.
2. ALDERTON F., LAUDER H., FENIUK W., FAN T. P. & HUMPREY P. P.: Differential effects of somatostatin and angiopeptin on cell proliferation. Br. J. Pharmacol. 124 (1998), 323.
3. ANVAR A., STRETZER S. H., HIDALGO B. O. et al.: Coronary stenting with a new ultra-short balloon expandable device. Early and late animal results. Cathet. Cardiovasc. Diagn. 31 (1994), 85.
4. ARAKAWA K., ISODA K., SUGIABU Y. et al.: Intimal proliferation after stenting reflected by increased stent-to-vessel cross-sectional area ratio. Serial intravascular ultrasound study. J. Cardiol. 32 (1998), 379.
5. ASAHARA T., BAUTERS C., PASTURE C. et al.: Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 91 (1995), 2793.
6. AZRIN M. A., MITCHEL J. F., FRAM D. B. et al.: Decreased platelet deposition and smooth muscle cell proliferation after intramural heparin delivery with hydrogel-coated balloons. Circulation 90 (1994), 433.
7. BACK M., KOPCHOK G., MUELLER M., CAVAYE D., DONAYRE C. & WHITE R. A.: Changes in arterial wall compliance after endovascular stenting. J. Vasc. Surg. 19 (1994), 905.
8. BAI H., MASUDA J., SAWA Y. et al.: Neointima formation after vascular stent implantation. Spatial and chronological distribution of smooth muscle cell proliferation and phenotypic modulation. Arterioscler. Thromb. 14 (1994), 1846.
9. BAIER R. E. & DUTTON R. C.: Initial events in interaction of blood with a foreign surface. J. Biomed. Mater. Res. 3 (1969), 191.
10. BALDUS S., KÖSTER R., ELSNER M. et al.: Treatment of aortocoronary vein graft lesions with membrane-covered stents. Circulation 102 (2000), 2024.
11. BARKER S. G. E., TALBERT A., COTTAM S., BASKER VILLE P. A. & MARTIN J. F.: Arterial intimal hyperplasia after occlusion of the adventitial vasa vasorum in the pig. Arterioscler. Thromb. 13 (1993), 70.
12. BARTH K. H., VIRMANI R., FROELICH J. et al.: Paired comparison of vascular wall reactions to Palmaz stents, Strecker tantalum stents, and Wallstents in canine iliac and femoral arteries. Circulation 93 (1996), 2161.
13. BARTH K. H., VIRMANI R., STRECKER E. P. et al.: Flexible tantalum stents implanted in aortas and iliac arteries. Effects in normal canines. Radiology 170 (1990), 91.
14. BECKER G. J., PALMAZ J. C., REES C. R. et al.: Angioplasty-induced dissections in human iliac arteries. Management with Palmaz balloon-expandable intraluminal stents. Radiology 176 (1990), 31.
15. BENDECK M. P., ZEMPO N., CLOWES A. W., GALARDY R. E. & REIDY M. A.: Smooth muscle cell migration and matrix metalloproteinease expression after arterial injury in the rat. Circ. Res. 75 (1994), 539.
16. BUCX J. J., DE SCHEERDER I., BEAT K. et al.: The importance of adequate anticoagulation to prevent early thrombosis after stenting of stenosed venous bypass grafts. Am. Heart J. 121 (1991), 1389.
17. BUERGLER J. M., TIO F. O., SCHULZ D. G. et al.: Use of nitric-oxide-eluting polymer-coated coronary stents for prevention of restenosis in pigs. Coron. Artery Dis. 11 (2000), 351.
18. CARTER A. J., LAIRD J. R., FARB A., KUFS W., WORTHAM D. C. & VIRMANI R.: Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model. J. Am. Coll. Cardiol. 24 (1994), 1398.
19. CASSCELLS W.: Growth factor therapies for vascular injury and ischemia. Circulation 91 (1995), 2699.
20. CHALMERS R. T., HOBALLAH J. J., SHARP W. J., KRESOWIK T. F. & CORSON J. D.: The effect of an intraluminal stent on neointimal hyperplasia at an end-to-side polytetrafluoroethylene graft arterial anastomosis. Am. J. Surg. 168 (1994), 85.
21. CHEN C., MATTAR S. G. & LUMSDEN A. B.: Oral administration of L-arginine reduces intimal hyperplasia in balloon-injured rat carotid artery. J. Surg. Res. 82 (1999), 1723.
22. CHEN D., ASAHARA T. KRASINSKI K. et al.: Antibody blockade of thrombospondin accelerates reendothelialization and reduces neointima formation in balloon-injured rat carotid artery. Circulation 100 (1999), 849.
23. CHOI E. T., ENGEL L., CALLOW A. D. et al.: Inhibition of neointimal hyperplasia by blocking alpha V beta3 integrin with a small peptide antagonist GpenGRGDSCPA. J. Vasc. Surg. 19 (1994), 125.
24. CHUAPETCHARASOPON C., WRIGHT K. C., WALLACE S., DOBBEN R. L. & GIANTURCO C.: Treatment of experimentally induced atherosclerosis in swine iliac arteries. A comparison of self-expanding and balloon-expanded stents. Cardiovasc. Intervent. Radiol. 15 (1992), 143.
25. CLOWES A. W. & REIDY M. A.: Prevention of stenosis after vascular reconstruction. Pharmacologic control of intimal hyperplasia - a review. J. Vasc. Surg. 13 (1991), 885.
26. CONSIGNY P. M., CRAGG A. H. & WALLER B. F.: Pathophysiology of vascular intervention. In: Vascular Diseases; Surgical and Interventional Therapy, p 31. Edited by D. E. Strandness Jr. Churchill Livingstone 1994.
27. CONSIGNY P. M., TULENKO T. N. & NICOSIA R. F.: Immediate and long-term effects of angioplasty-balloon dilation on normal rabbit iliac artery. Arteriosclerosis 6 (1996), 265.
28. CONTE M. S., CHOUDHRY R. P., SHIRAKOWA M., FALLON J. T. & BIRINYI L. K.: Endothelial cell seeding fails to attenuate intimal thickening in balloon-injured rabbit arteries. J. Vasc. Surg. 21 (1995), 413.
29. CURRIER J. W., POW T. K., HAUDENSCHILD C. C., MINIHAN A. C. & FAXON D. P.: Low molecular weight heparin reduces restenosis after iliac graft angioplasty in the hypercholesterolemic rabbit. J. Am. Coll. Cardiol. 17 (1991), 118 B.
30. ĆWIKIEL W. & HARNEK J.: New stent developed for carotid artery applications. Acta Radiol. 41 (2000), 601.
31. ĆWIKIEL W., HARNEK J., ZOUCAS E. & STENRAM U.: Proliferative reaction after PTA versus insertion of self-expandable stent. An experimental study. Acta Radiol. 38 (1997), 124.
32. DAKE M. D.: Peripheral angiography, angioplasty atherectomy, laser techniques, thrombolysis and stents. Curr. Opin. Radiol. 2 (1990), 239.
33. DAVIES M. G. & HAGEN P.-O.: The vascular endothelium. A new horizon. Ann. Surg. 218 (1993), 593.
34. DAVIES M. G., KIM J. H., DALEN H. et al.: Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine. Surgery 116 (1994), 557.
35. DEHMER G. J., POMPA J. J. & VAN DEN BERG E. K.: Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. J. Med. 319 (1988), 733.
36. DEITCH J. S., WILLIAMS J. K., ADAMS M. R. et al: Effects of beta3-integrin blockade (c7E3) on the response to angioplasty and intra-arterial stenting in atherosclerotic nonhuman primates. Arterioscler. Thromb. Vasc. Biol. 18 (1998), 1730.
37. DEUTSCHMANN H. A., SCHEDELBAUER P., BÉRCI V et al.: Placement of Hemobahn stent-grafts in femoropopliteal artery. Early experience and midterm results in 18 patients. J. Vasc. Interv. Radiol. 12 (2001), 943.
38. DICHEK D. A., NEVILLE R. F., ZWIEBEL J. A., FREEMAN S. M., LEON M. B. & ANDERSON W. F.: Seeding of intravascular stents with genetically engineered endothelial cells. Circulation 80 (1989), 1347.
39. DOTTER C. T., BUSCHMANN R. W., MC KINNEY M. K. & RÖSCH J.: Transluminal expandable nitinol coil stent grafting. Preliminary report. Radiology 147 (1983), 259.
40. DUPRAT G. JR, WRIGHT K. C., CHARNSANGAVEJ C., WALLACE S. & GIANTURCO C.: Flexible balloon-expanded stent for small vessels. Radiology 162 (1987), 276.
41. DUSSAILLANT G. R., MINTZ G. S., PICHARD A. D. et al.: Small stent size and intimal hyperplasia contribute to restenosis. A volumetric intravascular ultrasound analysis. J. Am. Coll. Cardiol. 26 (1995), 720.
42. DZAU V. J., GIBBONS G. H., COOKE J. P. & OMOIGUI N.: Vascular biology and medicine in 1990s. Scope, concepts, potentials, and perspectives. Circulation 87 (1993), 705.
43. EDELMAN E. R. & KARNOVSKY M. J.: Contrasting effects of the intermittent and continuous administration of heparin in experimental restenosis. Circulation 89 (1994), 770.
44. EDELMAN E. R., NUGENT M. A., SMITH L. T. & KARNOVSKY M. J.: Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries. J. Clin. Invest. 89 (1992), 465.
45. EMNÉUS H. & STENRAM U.: Metal implants in the human body. Acta Orthop. Scand. 36 (1965), 116.
46. FANG S., SHARMA R. V. & BAHALLA R. C.: Enhanced recovery of injury-caused downregulation of paxillinprotein by eNOS gene expression in rat carotid artery. Mechanism of NO inhibition of intimal hyperplasia? Arterioscler. Thromb. Vasc. Biol. 19 (1999), 147.
47. FARHY R. D., CARRETERO O. A., HO K.-L. & SCICLI A. G.: Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ. Res. 72 (1993), 1202.
48. FAXON D. P., COATS W. & CURRIER J.: Remodeling of the coronary artery after vascular injury. Prog. Cardiovasc. Dis. 40 (1997), 129.
49. FAXON D. P., SANBORN T. A., WEBER V. J. et al.: Restenosis following transluminal angioplasty in experimental atherosclerosis. Arteriosclerosis 4 (1984), 189.
50. FAXON D. P., SPIRO T. E., MINOR S. et al.: Low molecular weight heparin in prevention of restenosis after angioplasty. Results of enoxaparin restenosis (ERA) trial. Circulation 90 (1994), 908.
51. FERNANDEZ-ORTIZ A., MEYER B. J., MAILHAC A. et al.: A new approach for local intravascular drug delivery. Circulation 89 (1994), 1518.
52. FINGERLE J., Au J. P. T., CLOWES A. & REIDY M.: Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury. Arteriosclerosis 10 (1990), 1082.
53. FOEGH M. L., ASTORA S., CONTE J. V. et al.: Early inhibition of myointimal proliferation by angiopeptin after balloon catheter injury in the rabbit. J. Vasc. Surg. 19 (1994), 1084.
54. FONTAINE A., SPIGOS D. & EATON G.: Stent induced intimal hyperplasia. Are there fundamental differences between flexible and rigid stent designs? J. Vasc. Interv. Radiol. 5 (1994), 739.
55. FORTUNATO J. E., GLAGOV S. & BASSIOUNY H. S.: Irradiation for the treatment of intimal hyperplasia. Ann. Vasc. Surg. 12 (1998), 495.
56. FROEHLICH J. J., ALFKE H., WILKE A. et al.: Effects of nitinol Strecker stent placement on vascular response in normal and stenotic porcine iliac arteries. J. Vasc. Interv. Radiol. 10 (1999), 329.
57. FUESSL R. T., HOEPP H. W. & SECHTEM U.: Intravascular ultrasound in the evaluation of results of coronary angioplasty and stenting. Curr. Opin. Cardiol. 14 (1999), 471.
58. GARASIC J. M., EDELMAN E. R., SQUIRE J. C. et al.: Stent and artery geometry determinate intimal thickening independent of arterial injury. Circulation 101 (2000), 812.
59. GEARY R. L., KOYAMA N., WANG T. W. VERGEL S. & CLOWES A. W.: Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries. Circulation 91 (1995), 2972.
60. GEARY R. L., NIKKARI S. T., WAGNER W. D. et al.: Wound healing. A paradigm for lumen narrowing after arterial reconstruction. J. Vasc. Surg. 27 (1998), 96.
61. GELLMAN J., EZEKOWITZ M. D., SAREMBOCK I. J. et al.: Effect of lovastatin on intimal hyperplasia after balloon angioplasty. A study in an atherosclerotic hypercholesterolemic rabbit. J. Am. Coll. Cardiol. 17 (1991), 251.
62. GIAP H., TERSTEIN P., MASSULO V. & TRIPURANEMI P.: Barotrauma due to stent deployment in endovascular brachytherapy for restenosis prevention. Int. J. Radiat. Oncol. Biol. Phys. 47 (2000), 1021.
63. GORDON P. C., GIBSON M., COHEN D. J. et al.: Mechanism of restenosis and redilation within coronary stents - quantitative radiographic assessment. J. Am. Coll. Cardiol. 21 (1993), 1166.
64. GRAVANIS M. B. & ROUBIN G. S.: Histopathologic phenomena at the site of percutaneous transluminal coronary angioplasty. The problem of restenosis. Hum. Pathol. 20 (1989), 477.
65. GREENLEES C., WADSWORTH R. M., MARTORANA P. A. & WAINWRIGHT C. L.: The effects of L-arginine on neointimal formation and vascular function following balloon injury in heritable hyperlipidaemic rabbits. Cardiovasc. Res. 35 (1997), 351.
66. GRENADIER E., SHOFTI R., BEYAR M. et al.: Self-expandable and highly flexible nitinol stent. Immediate and long term results in dogs. Am. Heart J. 128 (1994), 870.
67. GRYGLEWSKI R. J.: Interactions between endothelial secretogogues. Ann. Med. 27 (1995), 421.
68. GÜNTHER R., VORWERK D. & ANTONUCCI F.: Iliac artery stenosis or obstruction after unsuccessful balloon angioplasty. Treatment with a self-expandable stent. AJR 156 (1991), 389.
69. HANKE H., HASSENSTEIN S., ULMER A. et al.: Accumulation of macrophages in arterial vessel wall following experimental balloon angioplasty. Eur. Heart J. 15 (1994), 691.
70. HARNEK J., ZOUCAS E., CARLEMALM E. & CWIKIEL W.: Endothelial damage after PTA or insertion of self-expandable stent. An experimental study. Cardiovasc. Intervent. Radiol. 22 (1999), 51.
71. HARRISON D. G.: The endothelial cell. Heart Dis. Stroke 1 (1992), 95.
72. HART C. E., KRAISS L. W., VERGEL S. et al.: PDGF beta receptor blockade inhibits intimal hyperplasia in the baboon. Circulation 99 (1999), 564.
73. HASEGAWA K., FUJIWARA H., DOYAMA K. et al.: Endothelin-1-selective receptor in the arterial intima of patients with hypertension. Hypertension 23 (1994), 288.
74. HAUSEGER K. A., CRAGG A. H., LAMMER J. et al.: Iliac artery stent placement. Clinical experience with a nitinol stent. Radiology 190 (1994), 199.
75. HAYRY P., MYLLARNIEMI M., AAVIK E. et al.: Stabile D-peptide analog of insulin-like growth factor-1 inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat. FASEB J. 9 (1995), 1336.
76. HECKER G., DENZER D. & WOHLFEIL S.: Elevation of circulating NO. Its effects on hemodynamics and vascular smooth muscle cell proliferation in rats. Agents Actions Suppl. 45 (1995), p. 169.
77. HEDIN M.: The origin of the word stent. Acta Radiol. 38 (1997), 937.
78. HENRY M., AMOR M., ETHEVENOT G. et al.: Palmaz stent placement in iliac and femoropopliteal arteries. Primary and secondary patency in 310 patients with 2-4 year follow-up. Radiology 197 (1995), 167.
79. HERBERT J. M., LAPLACE M. C., MARES A. M. & DOL M. F.: Platelet activating factor (PAF) is not an essential component of the cascade leading to smooth muscle cell proliferation following vascular injury. J. Lipid Mediat. Cell Signal. 12 (1995), 49.
80. HOFFER E. K. & SCAFANI S. J. A. The natural history of arterial injury. In: Current Techniques in Interventional Radiology, vol. 7, p. 1. Edited by C. Cope. Current Medicine, Philadelphia 1994.
81. HOFFMAN R., MINTZ G. S., MEHRAN R. et al.: Tissue proliferation within and surrounding Palmaz-Schatz stents is dependent on the aggressiveness of stent implantation technique. Am. J. Cardiol. 15 (1999), 1170.
82. HOFFMAN R., MINTZ G. S., PICHARD A. D. et al.: Intimal hyperplasia thickness at follow-up is independent of stent size. A serial intravascular ultrasound study. Am. J. Cardiol. 82 (1998), 1168.
83. HOLMES D. R., CAMRUD A. R., JORGENSON M. A., EDWARDS W. D. & SCHWARTZ R. S.: Polymeric stenting in the porcine coronary artery model. Differential outcome of exogenous fibrin sleeves versus polyurethane-coated stents. J. Am. Coll. Cardiol. 24 (1994), 525.
84. HONG M. K., PARK S. W. MOON D. H. et al.: Intravascular ultrasound analysis of beta radiation therapy for diffuse in-stent restenosis to inhibit intimal hyperplasia. Cathet. Cardiovasc. Interv. 45 (2001), 169.
85. HUMPHREY W. R., SIMMONS C. A., TOOMBS C. F. & SHEBUSKI R. J.: Induction of neointimal hyperplasia by coronary angioplasty balloon overinflation. Comparison of feeder pigs to Yucatan minipigs. Am. Heart J. 127 (1994), 20.
86. IACCARINO G., SMITHWICK L. A., LEFKOWITZ R. J. & KOCH W. J.: Targeting Gbeta gamma signaling in arterial vascular smooth muscle proliferation. A novel strategy to limit restenosis. Proc. Natl. Acad. Sci. USA 96 (1999), 3945.
87. IMPARATO A. M., BRACCO A., KIM G.-E. & ZEFF R.: Intimal and neointimal fibrous proliferation causing failure of arterial reconstruction. Surgery 72 (1972), 1007.
88. INDOLFI C., ESPOSITO G., DI LORENZO E. et al.: Smooth muscle cell proliferation is proportional to the degree of balloon injury in rat model of angioplasty. Circulation 92 (1995), 1230.
89. ISNER J. M., WALSH K., SYMES J. et al.: Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation 91, 2687. (1995).
90. JACKSON C. L. & PETTERSSON K. S.: Effects of probucol on rat carotid artery responses to balloon catheter injury. Atherosclerosis 154 (2001), 407.
91. JACKSON C. L., RAINES E. W., Ross R. & REIDY M. A.: Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler. Thromb. 13 (1993), 1218.
92. JACKSON C. L. & REIDY M. A.: Basic fibroblast growth factor. Its role in the control of smooth muscle cell migration. Am. J. Pathol. 143 (1993), 1024.
93. JOHNSTON K. W.: Femoral and popliteal arteries. Reanalysis of results of balloon angioplasty. Radiology 183 (1992), 767.
94. JOHNSTON K. W.: Iliac arteries. Reanalysis of results of balloon angioplasty. Radiology 186 (1993), 207.
95. KANDARAPA K., NAKATSUKA S., YOUSUF N. & BARRY J. J.: Site-specific delivery of iloprost during experimental angioplasty suppresses smooth muscle cell proliferation. J. Vasc. Interv. Radiol. 9 (1998), 487.
96. KAPLAN J., BARRY K. J., CONNOLLY R. J. et al.: Healing after arterial dilatation with radiofrequency thermal and non-thermal balloon angioplasty system. J. Invest. Surg. 6 (1993), 32.
97. KARAS S. P., GRAVANIS M. B., SANTOIAN E. C., ROBINSON K. A., ANDERBERG K. A. & KING S. B. III: Coronary intimal proliferation after balloon injury and stenting in swine. An animal model of restenosis. J. Am. Coll. Cardiol. 20 (1992), 467.
98. KASTRATI A., SCHOMIG A., DIRCHINGER J. et al.: Increased risk of restenosis after placement of gold-coated stents. Results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. Circulation 101 (2000), 2478.
99. KLINGE J., MALI W. P. T. M., PUIJLAERT C. B. A. et al.: Percutaneous transluminal renal angioplasty. Initial and long term results. Radiology 171 (1989), 501.
100. KNIGHT C. J., PANESAR M., WILSON D. J. et al.: Increased platelet responsiveness following coronary stenting. Heparin as a possible aetiological factor in stent thrombosis. Eur. Heart J. 19 (1998), 1239.
101. KOHLER T. R. & CLOWES A. W.: Response of artery to injury. The role of intimal hyperplasia in the failure of vascular reconstruction. In: Vascular Diseases; Surgical and Interventional Therapy, p. 17. Edited by D. E. Strandness Jr. Churchill Livingstone 1994.
102. + exchange. Circ. Res. 73 (1993), 264.
103. LAMURAGLIA G. M., CHANDRASEKAR N. R., FLOTTE T. J. et al.: Photodynamic therapy inhibition of experimental intimal hyperplasia. Acute and chronic effects. J. Vasc. Surg. 19 (1994), 321.
104. LAMAWANSA M. D., WYSOCKI S. J., HOUSE A. K. & NORMAN P. E.: Morphometric changes seen in balloon-injured porcine iliac arteries. The influence of sympathectomy on intimal hyperplasia and remodelling. Eur. J. Vasc. Endovasc. Surg. 13 (1997), 43.
105. LAMBERT T. L., DEV V., RECHAVIA E. et al.: Localized arterial wall drug delivery from a polymer-coated removable metallic stent. Kinetics, distribution and bioactivity of forskolin. Circulation 90 (1994), 1003.
106. LAMMER J.: Femoropopliteal artery obstructions. From the balloon to the stent graft. Cardiovasc. Intervent. Radiol. 24 (2001), 73.
107. LAW M. M., COLBURN M. D., HAJJAR G. E. et al: Suppression of intimal hyperplasia in a rabbit model of arterial balloon injury by enalaprilat but not dimethyl sulfonide. Ann. Vasc. Surg. 8 (1994), 158.
108. LAWRENCE M., WATSON L., PETTIJOHN T. et al.: Immunohistochemical localization of proliferating cells, basic fibroblast growth factor and Fos protein following iliac artery balloon angioplasty in hypercholesterolemic rabbit. In Vivo 9 (1995), 27.
109. LEHMANN K. G., POPMA J. J., WERNER J. A., LANSKY A. J. & WILENSKY R. L.: Vascular remodelling and the local delivery of cytochalasin B after coronary angioplasty in humans. J. Am. Coll. Cardiol. 35 (2000), 583.
110. LEMBO N. J. & ROUBIN G. S.: Intravascular stents. Cardiol. Clin. 7 (1989), 877.
111. LE TOURNEAU T., VAN BELLE E., CORSEAUX D. et al.: Role of nitric oxide in restenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit. Effects on neointimal hyperplasia and vascular remodelling. J. Am. Coll. Cardiol. 33 (1999), 876.
112. LEUNG D. Y. M., GLAGOV S. & MATHEWS M. B.: Cycling stretching stimulates synthesis of matrix components by arterial smooth muscle cells in vitro. Science 191 (1976), 475.
113. LE VEEN R. F., WOLF G. L. & VILLANUEVA T. G.: New rabbit atherosclerotic model for the investigation of transluminal angioplasty. Invest. Radiol. 17 (1982), 470.
114. LIERMAN D., BOTTCHER H. D., KOLLATH J. et al.: Prophylactic endovascular radiotherapy to prevent intimal hyperplasia after stent implantation in femoropopliteal arteries. Cardiovasc. Intervent. Radiol. 17 (1994), 12.
115. LIERMAN D., KIRCHNER J., BAUERNSACHS R., SCHOPOHL B. & BOTTCHER H. D.: Brachytherapy with iridium-192 HDR to prevent from restenosis in peripheral arteries. An update. Herz 23 (1998), 394.
116. LIMPUANKIT T., WAKSMAN R., YOCK P. G. & FITZGERALD P. J.: Intravascular ultrasound volumetric assessment of intimal hyperplasia in stents treated with intracoronary irradiation. Am. J. Cardiol. 84 (1999), 850.
117. LIU M. W., ANDERSON P. G., LUO J. F. & ROUBIN G. S.: Local delivery of ethanol inhibits intimal hyperplasia in pig coronary arteries after balloon injury. Circulation 96 (1997), 2295.
118. LONDON S. M. & MAYBERG M. R.: Kinetics of bromodeoxyuridine uptake by smooth muscle cells after arterial injury. J. Vasc. Res. 31 (1994), 247.
119. MATSI P. J., MANNINEN H. I., VANNINEN R. L. et al.: Femoropopliteal angioplasty in patients with claudication. Primary and secondary patency in 140 limbs with 1-3-year follow-up. Radiology 191 (1994), 727.
120. MATTSSON E. J., KOHLER T. R., VERGEL S. M. & CLOWES A. W.: Increased blood flow induces regression of intimal hyperplasia. Arterioscler. Thromb. Vasc. Biol. 17 (1997), 2245.
121. MC EVAN J.: Therapeutic approaches to the control of fibrocellular intimal hyperplasia after angioplasty. Br. Heart J. 70 (1993), 1.
122. MC NAMARA D. B., BEDI B., AURORA H. et al.: L-arginine inhibits balloon catheter-induced intimal hyperplasia. Biochem. Biophys. Res. Commun. 193 (1993), 291.
123. MEHRI Y., LACOSTE L. L. & LAM J. Y.: Neutrophil implications in platelet deposition and vasoconstriction after deep arterial injury by angioplasty in pigs. Circulation 90 (1994), 997.
124. MEHTA V. Y., JORGENSEN M. B., RAIZNER A. E. et al.: Spontaneous regression of restenosis. An angiographic study. J. Am. Coll. Cardiol. 26 (1995), 696.
125. MIKETIC S., CARLSSON J. & TEBBE U.: Influence of gradually increased slow balloon inflation on restenosis after coronary angioplasty. Am. Heart J. 135 (1998), 709.
126. MIYAUCHI K., AIKAWA M., TANI T. et al.: Effect of probucol on smooth muscle cell proliferation and dedifferentiation after vascular injury in rabbits. Possible role of PDGF. Cardiovasc. Drug Ther. 12 (1998), 251.
127. MONCADA S., PALMER R. & HIGGS E.: Nitric oxide. Physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43 (1991), 109.
128. MONDY J. S., WILLIAMS J. K., ADAMS M. R., DEAN R. H. & GEARY R. L.: Structural determinants of lumen narrowing after angioplasty in atherosclerotic nonhuman primates. J. Vasc. Surg. 26 (1997), 875.
129. MORE R. S., RUTTY G., UNDERWOOD M. J., BRACK M. J. & GERSHLICK A. H.: A time sequence of vessel wall changes in an experimental model of angioplasty. J. Pathol. 172 (1994), 287.
130. MORE R. S., UNDERWOOD M. J., BRACK M. J., DE BONO D. P. & GERSHLICK A. H.: Changes in vessel wall plasminogen activator activity and smooth muscle cell proliferation and activation after arterial injury. Cardiovasc. Res. 29 (1995), 22.
131. MOURA A., LAM J. Y. T., HÉBERT D. et al.: Intramural delivery of agent via a novel drug-delivery sleeve. Histological and functional evaluation. Circulation 92 (1995), 2299.
132. MULLER D. W., GOLOMB G., GORDON D. & LEVY R. J.: Site specific dexamethasone delivery for the prevention of neointimal thickening after vascular stent implantation. Coron. Artery Dis. 5 (1994), 435.
133. MURRAY J. G., APHTROP L. A. & WILKINS R. A.: Long-segment (>10 cm) femoropopliteal angioplasty. Improved technical success and long-term patency. Radiology 195 (1995), 158.
134. NABEL E. G., YANG Z., LIPTAY S. et al.: Recombinant platelet derived growth factor-B gene expression in porcine arteries induces intimal hyperplasia in vivo. J. Clin. Invest. 91 (1993), 1822.
135. NABEL E. G., YANG Z., PLAUTZ G. et al.: Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature 362 (1993), 844.
136. NARINS C. R., HILLEGASS W. B. JR, NELSON C. L. et al.: Relation between activated clotting time during angioplasty and abrupt closure. Circulation 93 (1996), 667.
137. NELSON P. R., YAMAMURA S., MUREEBE L., ITOH H. & KENT K. C.: Smooth muscle cell migration and proliferation are mediated by distinct phases of activation of intracellular messenger mitogen-activated protein kinase. J. Vasc. Surg. 27 (1998), 117.
138. NEWBY A. C. & HENDERSON A. H.: Stimulus-secretion coupling in vascular endothelial cells. Ann. Rev. Physiol. 52 (1990), 661.
139. NIKKARI S. T. & CLOWES A. W.: Restenosis after vascular reconstruction. Ann. Med. 26 (1994), 95.
140. NUGENT H. M., ROGERS C. & EDELMAN E. R.: Endothelial implants inhibit intimal hyperplasia after porcine angioplasty. Circ. Res. 84 (1999), 384.
141. OHNO T., GORDON D., SAN H. et al.: Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 265 (1994), 781.
142. OHSAWA H., NOIKE H., KANAI M. et al.: Preventive effects of an antiallergic drug, pemirolast potassium, on restenosis after percutaneous transluminal coronary angioplasty. Am. Heart J. 136 (1998), 1081.
143. ORTLI P., LA MURAGLIA G. M., ROBERTS W. G., FLOTTE T. J. & HASAN T.: Photodynamic therapy of arteries. A novel approach for treatment of experimental intimal hyperplasia. Circulation 58 (1992), 1189.
144. PALMAZ J. C.: Intravascular stenting. From basic research to clinical application. Cardiovasc. Intervent. Radiol. 15 (1992), 279.
145. PALMAZ J. C., GARCIA O. J., SCHATZ R. A. et al.: Placement of balloon-expandable intraluminal stents in iliac arteries. First 171 procedures. Radiology 174 (1990), 969.
146. PARK S., LEE C. W., KIM H. et al.: Effects of cilostazol on angiographic restenosis after coronary stent placement. Am. J. Cardiol. 86 (2000), 499.
147. PÄRSSON H., CWIKIEL W., JOHANSSON K., SWARTBOL P. & NORGREN L.: Deposition of platelets and neutrophils in porcine iliac arteries after angioplasty and Wallstent placement compared with angioplasty alone. Cardiovasc. Intervent. Radiol. 17 (1994), 190.
148. PASTORE C. J., ISNER J. M., BACHA P. A., KEARNEY M. & PICKERING J. G.: Epidermal growth factor receptor-targeted cytotoxin inhibits neointimal hyperplasia in vivo. Results of local versus systemic administration. Circ. Res. 77 (1995), 519.
149. PEACOCK J., HANKINS S., JONES T. & LUTZ R.: Flow instabilities induced by coronary artery stents. Assessment with an in vitro pulse duplicator. J. Biomech. 28 (1995), 17.
150. PEARSON J. D.: Endothelial cell biology. Radiology 179 (1991), 9.
151. PEPINE C. J., HIRSHFELD J. W., MACDONALD R. G. et al.: A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. Circulation 81 (1990), 1753.
152. PISCO J. CORRELA M., ESPERANCA-PINA J. A. & DE SOUSA L. A.: Vasa vasorum changes following stent placement in experimental arterial stenosis. J. Vasc. Interv. Radiol. 4 (1993), 269.
153. PISCO J., CORRELA M., ESPERANCA-PINA J. A. & DE SOUSA L. A.: Changes in the vasa vasorum following percutaneous transluminal angioplasty in a canine model of aortic stenosis. J. Vasc. Interv. Radiol. 5 (1994), 561.
154. POST M. J., BORST C. & KUNTZ R. K.: The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation 89 (1994), 2816.
155. POST M. J., DE SMET B. J., VAN DER HELM Y., BORST C. & KUNTZ R. E.: Arterial remodeling after balloon angioplasty or stenting in an atherosclerotic experimental model. Circulation 26 (1997), 996.
156. POWEL J. S., CLOZEL J.-R, MÜLLER R. K. M. et al.: Inhibitors of angiotensin converting enzyme prevent myointimal proliferation after vascular injury. Science 245 (1989), 186.
157. RAKUGI H., WANG D. S., DZAU V. J. & PRATT R. E.: Potential importance of tissue angiotensin converting enzyme inhibition in preventing neointima formation. Circulation 90 (1994), 449.
158. REES C. R., PALMAZ J. C., GARCIA O. et al.: Angioplasty and stenting of completely occluded iliac arteries. Radiology 172 (1989), 953.
159. REIDY M. A.: Biology of disease. A reassessment of endothelial injury and arterial lesion formation. Lab. Invest. 53 (1985), 513.
160. RICHTER G. M., PALMAZ J. C., NOELDGE G. & TIO F.: Relationship between blood flow, thrombus and neointima in stents. J. Vasc. Interv. Radiol. 10 (1999), 598.
161. RIES G. J., SIPPERLY M. E., MCCABE C. H. et al.: Randomized trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet 2 (1989), 1753.
162. ROALD H. E., OERVIM U., BAAKEN I. J., MARIUS BARSTAD R., KIERULF P. & SAKARIASSEN K. S.: Modulation of thrombotic responses in moderately stenosed arteries by cigarette smoking and aspirin ingestion. Arterioscler. Thromb. 14 (1994), 617.
163. ROBINSON K. A., ROUBIN G., KING S. et al.: Correlated microscopic observations of arterial responses to intravascular stenting. Scan. Microsc. 3 (1989), 665.
164. RODES J., COTE G., LESPERANCE J. et al.: Prevention of restenosis after angioplasty in smail coronary arteries with probucol. Circulation 97 (1998), 416.
165. ROEREN T., LE VEEN R. F., VILLANUEVA T. & REISMAN J.: Restenosis and successful angioplasty. Histologic-radiologic correlation. Radiology 172 (1989), 971.
166. ROGERS C., EDELMAN E. R. & SIMON D. I.: A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits. Proc. Natl. Acad. Sci. USA 95 (1998), 10134.
167. ROGERS C., KARNOVSKY M. J. & EDELMAN E. R.: Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration. Circulation 88 (1993), 1215.
168. ROLLAND P. H., CHARIFI A.-B., VERRIER C. et al.: Hemodynamics and wall mechanics after stent placement in swine iliac arteries. Comparative results from six stent designs. Radiology 213 (1999), 229.
169. Ross R.: The pathogenesis of atherosclerosis - an update. N. Engl. J. Med. 314 (1986), 488.
170. Ross R.: The pathogenesis of atherosclerosis. A perspective for the 1900s. Nature 362 (1993), 801.
171. ROUSSEAU H., JOFFRE F., RAILAT C. R. et al.: Self-expanding endovascular stent in experimental atherosclerosis. Radiology 170 (1989), 773.
172. ROUSSEAU H., RAILAT C. R., JOFFRE F., KNIGHT C. J. & GINESTET M. C.: Treatment of femoropopliteal stenoses by means of self-expandable endoprostheses. Midterm results. Radiology 172 (1989), 961.
173. SALAM T. A., TAYLOR B., SUGGS W. D., HANSON S. R. & LUMSDEN A. B.: Reaction to injury following balloon angioplasty and intravascular stent placement in the canine femoral artery. Am. Surg. 60 (1994), 353.
174. SANADA J. I., MATSUI O., YOSHIKAWA J. & MATSUOKA T.: An experimental study of endovascular stenting with special reference to the effects on the aortic vasa vasorum. Cardiovasc. Intervent. Radiol. 21 (1998), 45.
175. SAPOVAL M. R., LONG A. L., RAYNAUD A. C. et al.: Femoropopliteal stent placement. Long term results. Radiology 184 (1992), 833.
176. SAWA H., LUNGREN C., SOBEL B. E. & FUJII S.: Increased intramural expression of plasminogen activator inhibitor type 1 after balloon injury. A potential progenitor of restenosis. J. Am. Coll. Cardiol. 24 (1994), 1742.
177. SCHMITT R., CLOZEL J. P., IBERG N. & BÜHLER F. R.: Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel. Arterioscler. Thromb. Vasc. Biol. 15 (1995), 1161.
178. SCHOPOHL B., LIERMAN D., POHLIT L. J. et al.: 192IR endovascular brachytherapy for avoidance of intimal hyperplasia after percutaneous transluminal angioplasty and stent implantation in peripheral vessels. 6 years of experience. Int. J. Radiat. Oncol. Biol. Phys. 36 (1996), 835.
179. SCHULZ C., NIEDERER C., ANDRES C. et al.: Endovascular irradiation from B-particles-emitting gold stents results in increased neointima formation in a porcine restenosis model. Circulation 101 (2000), 1970.
180. SCHÜRMANN K., VORVERK D., KULISCH A. et al.: Neointimal hyperplasia in low-profile nitinol stents, Palmaz stents, and Wallstents. A comparative experimental study. Cardiovasc. Intervent. Radiol. 19 (1996), 248.
181. SCHÜRMANN K., VORVERK D., UPPENKAMP R. et al.: Determination of stent stenosis. An in vivo experimental comparison of intravascular ultrasound and angiography with histology. Cardiovasc. Intervent. Radiol. 21 (1998), 189.
182. SCHWARTZ L., LESPERANCE J., BOURASSA M. et al.: The role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplasty. Am. Heart J. 119 (1990), 232.
183. SCHWARTZ R. S., EDWARDS W. D., BAILEY K. et al.: Differential neointimal response to coronary artery injury in pigs and dogs. Implications for restenosis models. Arterioscler. Thromb. 14 (1994), 395.
184. SERRUYS P. W., JUILLIERE Y., BERTRAND M. E., PUEL J., RICKARDS A. F. & SIGWART U.: Additional improvement of stenosis geometry in human coronary arteries by stenting after balloon dilatation. Am. J. Cardiol. 61 (1988), 546.
185. SHEARS L. L. II, KIBBE M. R., MURDOCK A. D. et al.: Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo. J. Am. Coll. Surg. 187 (1998), 295.
186. SHIMOTAKAHARA S. & MAYBERG M. R.: Gamma irradiation inhibits neointimal hyperplasia in rats after arterial injury. Stroke 25 (1994), 424.
187. SINGH J. P., ROTHFUSS K. J., WIERNICKI T. R. et al.: Dipyridamole directly inhibits vascular smooth muscle cell proliferation in vitro and in vivo. Implications in the treatment of restenosis after angioplasty. J. Am. Coll. Cardiol. 23 (1994), 665.
188. SOLLOTT S. J., CHENG L., REBECCA R. P. et al.: Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J. Clin. Invest. 95 (1995), 1869.
189. SPAET T. H., STEMERMAN M. B., VEITH F. J. & LEJNIEKS I.: Intimal injury and regrowth in the rabbit aorta. Medial smooth muscle cells as a source of neointima. Circ. Res. 36 (1975), 58.
190. SPRAGUE E. A., LUO J. & PALMAZ J. C.: Human aortic endothelial cell migration onto stent surfaces under static and flow condition. J. Vasc. Interv. Radiol. 8 (1997), 83.
191. STADIUS M. L., GOWN A. M., KERNOFF R. & COLLINS C. L.: Cell proliferation after balloon injury of iliac arteries in the cholesterol-fed New Zealand rabbit. Arterioscler. Thromb. 14 (1994), 727.
192. STEFANIDIS C., TOUTOUZAS K., TSIAMIS E. et al.: Stents covered by an autologous arterial graft in porcine coronary arteries. Feasibility, vascular injury and effect on neointimal hyperplasia. Cardiovasc. Res. 41 (1999), 433.
193. STEG P. G., TAHLIL O., AUBAILLY N. et al.: Reduction of restenosis after angioplasty in an atheromatous rabbit model by suicide gene therapy. Circulation 96 (1997), 408.
194. STEPHAN D., SAN H., YANG Z. Y. et al.: Inhibition of vascular smooth muscle cell proliferation and intimal hyperplasia by gene transfer of beta-interferon. Mol. Med. 3 (1997), 593.
195. STRAUSS B. H., WILSON R. A., VAN HOUTEN R. et al.: Late effects of locally delivered mitomycin C on formation of neointima and on vasomotor response to acetylcholine. Coron. Artery Dis. 5 (1994), 633.
196. STRECKER E. P., GABELMAN A., Boos I. et al.: Effect on intimal hyperplasia of dexamethasone released from coated metal stents compared with non-coated stents in canine femoral arteries. Cardiovasc. Intervent. Radiol. 21 (1998), 487.
197. STRECKER E. P., HAGEN B., LIERMAN D. et al.: Iliac and femoropopliteal vascular disease treated with flexible tantalum stents. Cardiovasc. Intervent. Radiol. 16 (1993), 158.
198. SUTTON C. S., TOMINAGA R., HARASIKI H. et al.: Vascular stenting in normal and atherosclerotic rabbits. Circulation 81 (1990), 667.
199. TAKESHITA S., ZHENG L. P., BROGI E. et al.: Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularisation in rabbit ischemic hind limb model. J. Clin. Invest. 93 (1994), 662.
200. TANAKA H., SUKHOVA G. K., SWANSON S. J. et al.: Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation 88 (1993), 1788.
201. TARRY W. C. & MAKHOUL R. G.: L-arginine improves endothelium-dependent vasorelaxation and reduces intimal hyperplasia after balloon angioplasty. Arterioscler. Thromb. 14 (1994), 938.
202. TEIRSTEIN P. S., MASSULLO V., JANI S. et al.: Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N. Engl. J. Med. 336 (1997), 1697.
203. TETTEROO E., VAN DER GRAAF Y., BOSCH J. L. et al.: Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Lancet 351 (1998), 1153.
204. THE EPIC INVESTIGATORS: Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N. Engl. J. Med. 330 (1994), 956.
205. TOPOL E. J., CALIFF R. M., WEISMAN H. F. et al.: Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis. Results at six months. Lancet 343 (1994), 881.
206. TRACHTENBERG J. D., SUN S., CHOI E. T., CALLOW A. D. & RYAN U. S.: Effect of endothelin-1 infusion on the development of intimal hyperplasia after balloon catheter injury. J. Cardiovasc. Pharmacol. 22 (1993), Suppl. 8, p. 355.
207. TSUCHIKANE E., KOBAYASHI T. & AWATA N.: The potential of cilostazol in interventional cardiology. Curr. Interv. Cardiol. Rep. 2 (2000), 143.
208. UEDA M., BECKER A. E., NARUKO T. & KOJIMA A.: Smooth muscle cell de-differentiation is a fundamental change preceding wound healing after percutaneous transluminal coronary angioplasty in humans. Coron. Artery Dis. 6 (1995), 71.
209. UNDERWOOD P. A., MITCHELL S. M. & WHITELOCK J. M.: Heparin fails to inhibit the proliferation of human vascular smooth muscle cell in presence of human serum. J. Vasc. Res. 35 (1998), 449.
210. VAN BELLE E., MAILLARD L., TIO F. O. & ISNER J. M.: Accelerated endothelialization by local delivery of recombined human vascular endothelial growth factor reduces in-stent intimal formation. Biochem. Biophys. Res. Commun. 235 (1997), 311.
211. VAN BEUSEKOM H. M., WHELAN D. M., HOFMA S. H. et al.: Long term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries. J. Am. Coll. Cardiol. 32 (1998), 1109.
212. VAN LANKEREN W., GUSSENHOVEN E. J., VAN DER LUGT A. et al.: Intravascular sonographic evaluation of iliac artery angioplasty. What is the mechanism of angioplasty and can intravascular sonography predict clinical outcome? AJR 166 (1996), 1355.
213. VON DER LEYEN H. E., GIBBONS G. H., MORISHITA R. et al.: Gene therapy inhibiting neointimal vascular lesion. In vivo transfer of endothelial cell nitric oxide synthase gene. Proc. Natl. Acad. Sci. USA 92 (1995), 1137.
214. VORVERK D., REDHA F., NEUERBURG J., CLERC C. & GÜNTHER R. W.: Neointima formation following arterial placement of self-expanding stents of different radial force. Experimental results. Cardiovasc. Intervent. Radiol. 17 (1994), 27.
215. WAKSMAN R., ROBINSON K. A., CROCKER I. R. et al.: Intracoronary radiation decreases the second phase of intimal hyperplasia in a repeat balloon angioplasty model of restenosis. Int. J. Radiat. Oncol. Biol. Phys. 39 (1997), 475.
216. WALLER B. F., ORR C. M., PINKERTON C. A., VAN TASSEL J. W. & PINTO R. P.: Morphologic observations late after coronary balloon angioplasty. Mechanism of acute injury and relationship to restenosis. Radiology 174 (1990), 961.
217. WATANABE S., OSA A., SEKINE T. et al.: Production of radioactive endovascular stents by implantation of 133Xe ions. Appl. Radiat. Isot. 51 (1999), 197.
218. WEIDINGER F. F.: Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery. Circulation 81 (1990), 1667.
219. WHITE R. A. & DOUGLAS M. C.: Pathology of arterial disease. Influence of morphology and distribution of lesions on interventional therapy. J. Cardiovasc. Surg. 34 (1993), 105.
220. WHOLEY M. H., WHOLEY M., MATHIAS K. et al.: Global experience in cervical carotid artery stent placement. Cathet. Cardiovasc. Interv. 50 (2000), 160.
221. WILENSKY R. L., MARCH K. L., GRADUS-PIZLO I. et al.: Vascular injury, repair and restenosis after percutaneous transluminal angioplasty in atherosclerotic rabbit. Circulation 92 (1995), 2995.
222. WILENSKY R. L., TANGUAY J. F., ITO S. et al.: Heparin infusion prior to stenting (HIPS) trial. Final results of prospective, randomised controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia. Am. Heart J. 139 (2000), 1061.
223. WILSON N. V., SAILSBURY J. R. & KAKKAR V. V.: The effect of low molecular heparin on intimal hyperplasia in vein grafts. Eur. J. Vasc. Surg. 8 (1994), 60.
224. YAMASAKI M., HARA K., IKARI Y. et al.: Effect of cilostazol on late lumen loose after Palmaz-Schatz stent implantation. Cathet. Cardiovasc. Diagn. 44 (1998), 387.